Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/37013| Title: | mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients? | Authors: | Wijtvliet, Veerle P. W. M. Arien, Kevin K. ABRAMS, Steven Couttenye, Marie M. Mestrez, Fabienne Marien , Joachim De Winter, Benedicte Y. Van Damme , Pierre Pipeleers, Lissa Wissing, Karl Martin Abramowicz, Daniel Ledeganck, Kristien J. |
Issue Date: | 2022 | Publisher: | OXFORD UNIV PRESS | Source: | Nephrology, dialysis, transplantation, 37 (4) , p. 799-803 | Notes: | Wijtvliet, VPWM (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium.; Wijtvliet, VPWM (corresponding author), Univ Antwerp, Infla Med Ctr Excellence, Antwerp, Belgium.; Wijtvliet, VPWM (corresponding author), Antwerp Univ Hosp, Dept Nephrol & Hypertens, Edegem, Belgium. veerle.wijtvliet@uantwerpen.be |
Keywords: | Antibodies, Viral;BNT162 Vaccine;COVID-19 Vaccines;Humans;Renal Dialysis;Transplant Recipients;2019-nCoV Vaccine mRNA-1273;Kidney Transplantation | Document URI: | http://hdl.handle.net/1942/37013 | ISSN: | 0931-0509 | e-ISSN: | 1460-2385 | DOI: | 10.1093/ndt/gfab352 | ISI #: | WOS:000764777200001 | Rights: | The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2023 |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| gfab352.pdf | Published version | 223.9 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.